BCT

COM:BRIACELL

BriaCell Therapeutics Corp.

  • Stock

CAD

Last Close

1.09

22/11 20:59

Market Cap

24.87M

Beta: -

Volume Today

102.31K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jul '14
Jul '15
Jul '16
Jul '17
Jul '18
Jul '19
Jul '20
Jul '21
Jul '22
Jul '23
Jul '24
average inventory
0.00
-
0.00
0%
-0.00
-
-0.00
0%
2.84M
-
average payables
231.64K
-
793.51K
242.56%
4.15M
422.65%
average receivables
8.78K
-
17.16K
95.55%
14.92K
13.10%
4.14K
72.28%
10.08K
143.81%
8.60K
14.73%
11.62K
35.21%
16.60K
42.77%
18.34K
10.50%
21.49K
17.17%
693.94K
3,129.45%
book value per share
12.73
-
4.65
63.47%
2.73
41.34%
2.13
22.11%
2.21
3.93%
-1.11
150.26%
-4.61
315.70%
3.75
181.26%
0.67
82.25%
-0.24
136.33%
capex per share
-2.44
-
-0.01
99.71%
capex to depreciation
-130.16
-
-4.01
96.92%
5.44
-
capex to operating cash flow
0.40
-
0.00
99.53%
-0.02
-
capex to revenue
cash per share
13.66
-
4.85
64.50%
2.84
41.34%
4.58
60.95%
4.09
10.69%
0.25
93.81%
0.03
89.23%
3.75
13,660.17%
2.64
29.48%
1.36
48.56%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.49
-
0.73
47.89%
0.48
34.07%
0.00
99.91%
debt to equity
1.19
-
-0.47
139.49%
-0.07
85.17%
0.00
100.65%
dividend yield
earnings yield
-2.85
-
-0.16
94.48%
-0.09
45.38%
-0.15
79.02%
0.06
140.30%
0.05
13.28%
0.21
281.16%
-0.04
118.15%
-0.12
212.23%
-0.20
71.07%
enterprise value
2.05M
-
16.68M
713.42%
19.59M
17.45%
15.78M
19.47%
17.57M
11.39%
11.36M
35.36%
6.96M
38.71%
20.56M
195.29%
58.65M
185.25%
80.91M
37.96%
-862.09K
101.07%
enterprise value over ebitda
0.28
-
-87.06
31,025.69%
-12.00
86.22%
-6.13
48.93%
16.30
366.03%
11.82
27.46%
4.98
57.90%
5.55
11.46%
-5.10
191.88%
-3.62
29.05%
ev to operating cash flow
-5.63
-
-17.84
216.55%
-16.34
8.40%
-10.28
37.11%
-4.62
55.07%
-2.93
36.51%
-6.01
104.87%
-2.65
55.82%
-4.70
77.03%
-3.41
27.47%
0.04
101.05%
ev to sales
free cash flow per share
-8.61
-
-3.76
56.34%
-4.16
10.55%
-4.35
4.62%
-8.90
104.52%
-6.68
24.86%
-1.62
75.71%
-0.51
68.75%
-0.80
58.56%
-1.52
88.96%
free cash flow yield
-0.18
-
-0.05
69.09%
-0.06
10.55%
-0.09
50.39%
-0.22
142.38%
-0.35
56.04%
-0.17
50.36%
-0.10
41.99%
-0.13
25.76%
-0.23
85.59%
graham net net
-17.39
-
4.46
125.65%
2.68
39.85%
2.08
22.45%
0.98
52.77%
-1.57
259.76%
-5.24
233.43%
3.70
170.67%
0.57
84.65%
-0.62
209.09%
graham number
198.89
-
33.56
83.13%
19.00
43.39%
18.71
1.51%
11.12
40.55%
5.10
54.19%
14.19
178.47%
4.00
71.82%
3.34
16.41%
2.66
20.45%
income quality
0.04
-
0.35
680.56%
0.71
102.78%
0.59
15.99%
0.92
54.20%
0.88
3.94%
0.31
64.26%
18.09
5,650.55%
0.47
97.43%
1.17
151.43%
4.89
318.29%
intangibles to total assets
0
-
0.00
Infinity%
0.00
52.10%
0.00
46.47%
0.12
24,518,312.00%
0.62
416.47%
0.50
19.57%
0.00
99.15%
0.01
27.85%
0.01
46.35%
0.03
329.73%
interest coverage
-36.45
-
-203.09
457.21%
-459.52
126.26%
-500.66
8.95%
-244.38
51.19%
39.74
116.26%
51.29
29.07%
80.05
56.07%
-15.62K
19,609.61%
interest debt per share
0.20
-
0.03
86.00%
0.01
55.82%
0.01
16.19%
2.66
18,077.95%
0.56
78.88%
0.36
36.13%
0.00
98.68%
0.00
98.66%
inventory turnover
invested capital
1.19
-
-0.47
139.49%
-0.07
85.17%
0.00
100.65%
-3.22M
-
market cap
2.86M
-
17.04M
496.41%
19.72M
15.76%
16.79M
14.87%
17.17M
2.27%
11.20M
34.75%
6.75M
39.73%
77.80M
1,052.06%
99.69M
28.13%
102.16M
2.48%
net current asset value
698.29K
-
1.13M
61.65%
784.75K
30.48%
748.33K
4.64%
537.52K
28.17%
-901.46K
267.71%
-3.53M
291.95%
57.02M
1,713.69%
10.10M
82.29%
-3.99M
139.53%
-4.90M
22.82%
net debt to ebitda
-0.11
-
1.86
1,784.91%
0.08
95.68%
0.39
389.04%
0.37
5.74%
0.16
56.67%
0.15
7.02%
-15.45
10,424.09%
3.57
123.09%
0.95
73.37%
net income per share
-138.07
-
-10.76
92.20%
-5.88
45.38%
-7.32
24.54%
2.49
134.01%
1.04
58.24%
1.94
86.54%
-0.19
109.77%
-0.75
293.67%
-1.30
74.17%
operating cash flow per share
-6.17
-
-3.75
39.15%
-4.16
10.76%
-4.35
4.62%
-8.90
104.52%
-6.68
24.86%
-1.62
75.71%
-0.51
68.75%
-0.80
58.56%
-1.52
88.96%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-3.15
-
-2.10
33.22%
-2.03
3.44%
-1.58
22.16%
0.53
133.55%
3.83
622.42%
5.78
51.08%
-0.05
100.87%
-0.27
446.05%
-0.75
175.48%
revenue per share
roe
-10.84
-
-2.31
78.66%
-2.15
6.90%
-3.44
59.89%
1.13
132.72%
-0.94
183.10%
-0.42
55.13%
-0.05
87.97%
-1.12
2,117.93%
5.38
579.40%
roic
-1.13
-
-1.82
60.49%
-2.15
18.49%
-3.44
59.90%
-2.40
30.23%
-1.76
26.70%
-0.48
73.02%
-0.05
89.37%
-1.48
2,837.25%
6.16
515.14%
sales general and administrative to revenue
shareholders equity per share
12.73
-
4.65
63.47%
2.73
41.34%
2.13
22.11%
2.21
3.93%
-1.11
150.26%
-4.61
315.70%
3.75
181.26%
0.67
82.25%
-0.24
136.33%
stock based compensation to revenue
tangible asset value
751.30K
-
1.16M
54.28%
787.10K
32.09%
750.23K
4.68%
670.28K
10.66%
-901.46K
234.49%
-3.53M
291.95%
57.02M
1,713.69%
10.10M
82.29%
-3.99M
139.53%
-2.88M
27.74%
tangible book value per share
12.73
-
4.65
63.47%
2.73
41.34%
2.13
22.11%
1.57
26.29%
-1.56
199.26%
-4.95
218.25%
3.73
175.44%
0.65
82.57%
-0.26
139.28%
working capital
698.29K
-
1.13M
61.65%
784.75K
30.48%
748.33K
4.64%
537.52K
28.17%
-901.46K
267.71%
-3.39M
276.11%
57.24M
1,788.30%
41.41M
27.66%
25.15M
39.27%
-3.81M
115.14%

All numbers in CAD (except ratios and percentages)